Doherty et al. displayed that patients with IBD were characterized by an increased numbers of circulating and colonic CD73+CD4+ T cells during the active phase of inflammation and such an increase was counteracted following anti-TNF treatment (55). Here, NT5E is linked to inflammatory bowel disease.